0001876967-26-000002.txt : 20260824 0001876967-26-000002.hdr.sgml : 20260824 20260824162545 ACCESSION NUMBER: 0001876967-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260824 DATE AS OF CHANGE: 20260824 EFFECTIVENESS DATE: 20260824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Unravel Biosciences, Inc. CENTRAL INDEX KEY: 0001876967 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-595175 FILM NUMBER: 261310871 BUSINESS ADDRESS: STREET 1: 100 WILLIAM T. MORRISSEY BLVD. STREET 2: VENTURE DEVELOPMENT CENTER CITY: BOSTON STATE: MA ZIP: 02125 BUSINESS PHONE: 510-984-2317 MAIL ADDRESS: STREET 1: 100 WILLIAM T. MORRISSEY BLVD. STREET 2: VENTURE DEVELOPMENT CENTER CITY: BOSTON STATE: MA ZIP: 02125 D 1 primary_doc.xml X0708 D LIVE 0001876967 Unravel Biosciences, Inc. 196 BOSTON AVE., SUITE 1000 MEDFORD MA MASSACHUSETTS 02155 510-984-2317 DELAWARE None None Corporation true Richard Novak 196 Boston Ave., Suite 1000 Medford MA MASSACHUSETTS 02155 Executive Officer Director Frederic Vigneault 196 Boston Ave., Suite 1000 Medford MA MASSACHUSETTS 02155 Director Donald Ingber 196 Boston Ave., Suite 1000 Medford MA MASSACHUSETTS 02155 Director Biotechnology Decline to Disclose 06b false 2026-08-07 false true true false 0 4500000 4100000 400000 false 2 0 0 0 false Unravel Biosciences, Inc. /s/ Richard Novak Richard Novak Chief Executive Officer 2026-08-24